硫唑嘌呤用于多发性硬化症的长期治疗。
Long-term treatment of multiple sclerosis with azathioprine.
作者信息
Swinburn W R, Liversedge L A
出版信息
J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):124-6. doi: 10.1136/jnnp.36.1.124.
Abstract
Nineteen patients with multiple sclerosis were treated with azathioprine for two years. There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 24 control patients observed over the same period.
摘要
19名多发性硬化症患者接受了硫唑嘌呤治疗，为期两年。与同期观察的24名对照患者相比，没有证据表明该治疗能预防病情恶化或减少复发次数及减轻复发的严重程度。
相似文献
1
Long-term treatment of multiple sclerosis with azathioprine.硫唑嘌呤用于多发性硬化症的长期治疗。
J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):124-6. doi: 10.1136/jnnp.36.1.124.
2
Overview of azathioprine treatment in multiple sclerosis.
Lancet. 1991 Oct 26;338(8774):1051-5. doi: 10.1016/0140-6736(91)91909-e.
3
Prolonged azathioprine treatment of non-remitting multiple sclerosis.硫唑嘌呤长期治疗不缓解型多发性硬化症。
J Neurol Neurosurg Psychiatry. 1979 Apr;42(4):338-44. doi: 10.1136/jnnp.42.4.338.
4
Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.硫唑嘌呤治疗多发性硬化症——一项关于其疗效的3年对照研究
J Neurol. 1980;223(2):97-117. doi: 10.1007/BF00313173.
5
[Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
Rev Neurol (Paris). 1984;140(2):125-30.
6
The efficacy of azathioprine in relapsing-remitting multiple sclerosis.
Neurology. 1991 Jan;41(1):20-5. doi: 10.1212/wnl.41.1.20.
7
[Haematological changes following long-term treatment of multiple sclerosis and myasthenia with azathioprin (author's transl)].
Nervenarzt. 1982 Feb;53(2):105-9.
8
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.硫唑嘌呤治疗多发性硬化症引发癌症的风险：一项病例对照研究。
Neurology. 1996 Jun;46(6):1607-12. doi: 10.1212/wnl.46.6.1607.
9
Multiple sclerosis unaffected by azathioprine in pilot study.
Arch Neurol. 1973 Mar;28(3):210-2. doi: 10.1001/archneur.1973.00490210090017.
10
A long-term double-blind controlled study on the effect of azathioprine in the treatment of multiple sclerosis.
Clin Neurol Neurosurg. 1988;90(1):25-8. doi: 10.1016/s0303-8467(88)80005-2.
引用本文的文献
1
Azathioprine for people with multiple sclerosis.硫唑嘌呤用于多发性硬化症患者。
Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2.
2
Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?醋酸格拉替雷治疗多发性硬化症：一种用于靶向先天性和适应性免疫系统炎症机制的随机共聚物工具箱？
Int J Mol Sci. 2012 Nov 9;13(11):14579-605. doi: 10.3390/ijms131114579.
3
Azathioprine. Safety profile in multiple sclerosis patients.硫唑嘌呤。多发性硬化症患者的安全性概况。
Neurol Sci. 2007 Dec;28(6):299-303. doi: 10.1007/s10072-007-0842-9.
4
Azathioprine for multiple sclerosis.硫唑嘌呤用于治疗多发性硬化症。
Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD003982. doi: 10.1002/14651858.CD003982.pub2.
5
Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis.英国政府用于评估治疗多发性硬化症药物的风险分担计划存在的问题。
BMJ. 2003 Feb 15;326(7385):388-92. doi: 10.1136/bmj.326.7385.388.
6
A double blind study on azathioprine efficacy in multiple sclerosis: final report.一项关于硫唑嘌呤治疗多发性硬化症疗效的双盲研究：最终报告。
J Neurol. 1993 May;240(5):295-8. doi: 10.1007/BF00838165.
7
Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.类固醇和免疫抑制的作用以及干扰素β-1b在多发性硬化症中的效果。
West J Med. 1994 Sep;161(3):292-8.
8
Immunological treatment of multiple sclerosis.多发性硬化症的免疫治疗
J Neurol. 1983;230(2):73-80. doi: 10.1007/BF00313634.
9
Effectiveness of azathioprine treatment in multiple sclerosis.
Ital J Neurol Sci. 1988 Jun;9(3):261-4. doi: 10.1007/BF02334050.
10
Double-blind controlled trial of azathioprine in the treatment of multiple sclerosis.硫唑嘌呤治疗多发性硬化症的双盲对照试验。
J Neurol Neurosurg Psychiatry. 1987 Oct;50(10):1387. doi: 10.1136/jnnp.50.10.1387.
本文引用的文献
1
On the evaluation of disability in multiple sclerosis.关于多发性硬化症残疾情况的评估。
Neurology. 1961 Aug;11:686-94. doi: 10.1212/wnl.11.8.686.
2
A preliminary evaluation of azathioprine (Imuran) in the treatment of multiple sclerosis.
Henry Ford Hosp Med J. 1969 Summer;17(2):89-92.
3
Azathioprine therapy of "autoimmune" diseases.
Am J Med. 1966 Sep;41(3):404-12. doi: 10.1016/0002-9343(66)90086-6.
4
[Immunosuppressive therapy of multiple sclerosis. 1. Preliminary communication on the results of treatment with azathioprine and anti-lymphocytic globulin].
Munch Med Wochenschr. 1971 Feb 12;113(7):221-31.
5
Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
Schweiz Arch Neurol Neurochir Psychiatr. 1969;105(2):241-6.
6
Long-term treatment of multiple sclerosis with corticotrophin.用促肾上腺皮质激素对多发性硬化症进行长期治疗。
Lancet. 1967 Aug 26;2(7513):429-31. doi: 10.1016/s0140-6736(67)90850-1.
7
Therapeutic trial of Imuran (azathioprine) in multiple sclerosis.
Acta Neurol Scand. 1971;47(2):254-60. doi: 10.1111/j.1600-0404.1971.tb07480.x.
Zotero 插件